Is the security of america at risk . And covid continues to peek across the country, once again shutting new york city Public Schools down. With vaccines on the way but still not quite ready, we speak to 23andme ceo Anne Wojcicki. Could their research on genes and covid give us more clues on how to fight it faster . Dropping asstocks fresh resections put in place to limit the spread of covid19 overshadowed positive news. About vaccine develop at Abigail Doolittle has more. Generally the markets were quieter today, but then it fell off late in the day. Abigail truly a sleeper for much of the day. Cyclical rotation trying to take over. As new york city headlines crossed on top of the mta news around the subway. Earlier today, two negative headlines. Of course the second one being that schools are shutting tomorrow until at least after thanksgiving on the 3 seven day rolling Positivity Rate here in new york city, at least according to the mayors office. Looks like the governor may have ha
And covid continues to peak across the country, once again shutting new york city Public Schools down. With vaccines on the way but still not quite ready, we speak to 23andme ceo Anne Wojcicki. Could their research on genes and covid give us more clues on how to fight it faster . All of those stories in a moment, but first, u. S. Stocks dropping as fresh resections put in place to limit the spread of covid19 overshadowed positive news about Vaccine Development. Our Abigail Doolittle has more. Abigail, generally the markets were quieter today, but then it fell off late in the day. Abigail yeah, truly a sleeper for much of the day. Very small, fluctuating moves. Cyclical rotation trying to take over. Then new york city headlines crossed on top of the mta news around the subway. Earlier today, you had these two negative headlines. Of course the second one being that schools are shutting tomorrow until at least after thanksgiving on the 3 , sevenday rolling Positivity Rate here in new york
Happened with astrazeneca, what is your best estimate for when a safe vaccine will be available . Dr. Redfield one thing i have learned is the cdc director, i business. The opinion im in the data and signs of it. What does the data and signs suggest . Dr. Redfield based on enrollment right now that is going on with the pfizer and moderna, that it is conceptual that they will have enough data to present it to the fda for evaluation somewhere before the end of october and the end of november. The reason i cannot be more specific is because these trials are event driven trials. They are 100 dependent on how much covid occurs in the volunteer population. If it is a lot of these individuals having to get covid independent of what group they are in, and the potential for them to have enough events if the vaccine is very efficacious will be in the october timeframe. If the vaccine is 50 efficacious, it might be in the late november timeframe. If there are fewer events and it vaccine, andd mig
A government review in early october. Moderna had talked about a phase three trial in september. Astrazeneca before this is in phase three. Backdrop and what happened with astrazeneca, what is your best estimate for when a safe vaccine will be available . Dr. Redfield one thing i have learned is the cdc director, i business. The opinion im in the data and signs of it. What does the data and signs suggest . Dr. Redfield based on enrollment right now that is going on with the pfizer and moderna, that it is conceptual that they will have enough data to present it to the fda for evaluation somewhere before the end of october and the end of november. The reason i cannot be more specific is because these trials are event driven trials. They are 100 dependent on how much covid occurs in the volunteer population. If it is a lot of these individuals having to get covid independent of what group they are in, and the potential for them to have enough events if the vaccine is very efficacious will
At when a vaccine will be available . Business. E opinion im in the data and signs of it. What does the data and signs suggest . Dr. Redfield based on enrollment right now that is going on with the pfizer and moderna, that it is conceptual that they will have enough data to present it to the fda for evaluation somewhere before the end of october and the end of november. The reason i cannot be more specific is because these trials are event driven trials. They are 100 dependent on how much covid occurs in the volunteer population. If it is a lot of these individuals having to get covid independent of what group they are in, and the potential for them to have enough events if the vaccine is very efficacious will be in the october timeframe. If the vaccine is 50 efficacious, it might be in the late november timeframe. If there are fewer events and it vaccine, andd might be in december. Somewhere between the end of october and the end of the year is probably it is probable one or more of t